Ana Laura Espinosa de los Monteros Carmen A Carrasco Alfredo Adolfo Reza Albarrán Mônica Gadelha Alin Abreu Moisés Mercado
10.1007/s11102-013-0530-0
Pituitary
2014 Jan;17 Suppl 1(Suppl 1):S4-10.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24166706/
Acromegaly / drug therapy Adenoma / drug therapy Ergolines / therapeutic use Octreotide / therapeutic use Pituitary Neoplasms / drug therapy
Acromegaly / drug therapy Adenoma / drug therapy Ergolines / therapeutic use Octreotide / therapeutic use Pituitary Neoplasms / drug therapy Case Reports Adenoma / pathology Cabergoline Dopamine Agonists / therapeutic use Human Growth Hormone / analogs & derivatives Human Growth Hormone / economics Human Growth Hormone / therapeutic use Humans Male Pituitary Neoplasms / pathology Somatostatin / analogs & derivatives Somatostatin / therapeutic use Young Adult Dopamine Agonists Ergolines Human Growth Hormone Somatostatin Cabergoline pegvisomant Octreotide
PMC3906545
24166706
The role of primary pharmacological therapy in acromegaly
2014